Publisher’s Note: Thanks to a Vermont neighbor for sending on this PCR test label verbiage. As even the COVID-happy New York Times and Bill “Dr. Vax” Gates have admitted, the use of the PCR (Polymerase Chain Reaction) Test as a viral remedy for the “novel corona virus” is deeply flawed (“Completely Garbage,” says Gates). Worse, reliance on PCR testing’s “Garbage In, Garbage Out” (GIGO) data is creating a CASEdemic across the United States. To wit: saying that “COVID cases are spiking” means that PCR testing is detecting viral material in Human orifices that have little to no bearing on actual COVID-19 viral detection, as the PCR test’s brilliant scientific inventor, Kary Mullis warned us many years ago, unequivocally stating that PCR tests should never be used to diagnose the presence of viruses (Here’s a link to in which Mullis states this, not once, but several times in different scenarios.) Case in point: the six sentence PCR testing label below from the University of Vermont’s own on-campus laboratory, with helpful sentence by sentence translation included below the official label. The continued use of PCR tests is NONsense, and decidedly UNscientific. Below, the label verbiage:

Results are presumptive for the detection and identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in the nasopharynx and oropharynx during the acute phase of infection. Positive results are indicative of active infection with SARS-CoV-2 but do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. In addition, nucleic acid detection can persist following clearance of active viral replication. Laboratories within the United States and its territories are required to report all positive results to the appropriate public health authorities.

Translation:

1. Results are presumptive for the detection and identification of SARS-CoV-2 RNA (“Presumptive” means “based on inference, assumed”). 2. The SARS-CoV-2 RNA is generally detectable in the nasopharynx and oropharynx during the acute phase of infection. (nasopharynx: the part of the pharynx behind and above the soft palate, directly continuous with the nasal passages, and oropharynx: the part of the pharynx between the soft palate and the upper edge of the epiglottis.) 3. Positive results are indicative of active infection with SARS-CoV-2 but do not rule out bacterial infection or co-infection with other viruses. (NOTE last phrase here, and following sentence). 4. The agent detected may not be the definite cause of disease. 5. In addition, nucleic acid detection can persist following clearance of active viral replication.(NOTE: this means that the the virus might be gone, even if the PCR test provides a positive result indicating the virus is “present”??!!). 6. Laboratories within the United States and its territories are required to report all positive results to the appropriate public health authorities. (NOTE: Why, given the numerous disclaimers on this label?)

The UVM PCR Test: Background:

UVM has partnered with the Broad Institute Clinical Research Sequency Platform (CRSP) to provide routine COVID-19 testing. The CRSP SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic Assay is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal and oropharyngeal swabs collected from individuals.